Publications 2024

Extracellular vesicles as human therapeutics: A scoping review of the literature.

Fusco C, De Rosa G, Spatocco I, Vitiello E, Procaccini C, Frigè C, Pellegrini V, La Grotta R, Furlan R, Matarese G, Prattichizzo F, de Candia P.
Extracell Vesicles. 2024 May;13(5):e12433. doi: 10.1002/jev2.12433.

Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.

Abbadessa G, Lepore MT, Bruzzaniti S, Piemonte E, Miele G, Signoriello E, Perna F, De Falco C, Lus G, Matarese G, Bonavita S, Galgani M.
Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200250. doi: 10.1212/NXI.

Cellular and molecular signaling towards T cell immunological self-tolerance.

Carbone F, Russo C, Colamatteo A, La Rocca C, Fusco C, Matarese A, Procaccini C, Matarese G.
J Biol Chem. 2024 Mar 1:107134. doi: 10.1016/j.jbc.2024.107134.

Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children.

Bruzzaniti S, Piemonte E, Bruzzese D, Lepore MT, Strollo R, Izzo L, Di Candia F, Franzese A, Bifulco M, Mozzillo E, Ludvigsson J, Matarese G, Galgani M.
Diabetologia. 2024 Jan 12. doi: 10.1007/s00125-023-06075-3.

Mycobacterium tuberculosis Antigen 85B modifies BCG-induced anti-tuberculosis immunity and favors pathogen survival.

Piccaro G, Aquino G, Gigantino V, Tirelli V, Sanchez M, Iorio E, Matarese G, Cassone A, Palma C.
J Leukoc Biol. 2024 Jan 18:qiae014. doi: 10.1093/jleuko/qiae014.